EE200300491A - 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena - Google Patents

6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena

Info

Publication number
EE200300491A
EE200300491A EEP200300491A EEP200300491A EE200300491A EE 200300491 A EE200300491 A EE 200300491A EE P200300491 A EEP200300491 A EE P200300491A EE P200300491 A EEP200300491 A EE P200300491A EE 200300491 A EE200300491 A EE 200300491A
Authority
EE
Estonia
Prior art keywords
kinase inhibitors
substituted indolinones
indolinones
substituted
kinase
Prior art date
Application number
EEP200300491A
Other languages
English (en)
Estonian (et)
Inventor
Hilberg Frank
Heckel Armin
Lehmann-Lintz Thorsten
J�rgen Roth Gerald
Kley J�rg
C. A. Van Meel Jacobus
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300491A publication Critical patent/EE200300491A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
EEP200300491A 2001-04-06 2002-03-30 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena EE200300491A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10117204A DE10117204A1 (de) 2001-04-06 2001-04-06 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2002/003583 WO2002081445A1 (de) 2001-04-06 2002-03-30 In 6-stellung substituierte indoline und ihre verwendung als kinase-inhibitoren

Publications (1)

Publication Number Publication Date
EE200300491A true EE200300491A (et) 2004-02-16

Family

ID=7680648

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300491A EE200300491A (et) 2001-04-06 2002-03-30 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena

Country Status (23)

Country Link
US (1) US6858641B2 (de)
EP (1) EP1379501A1 (de)
JP (1) JP2004525173A (de)
KR (1) KR20030090712A (de)
CN (1) CN1509270A (de)
AR (1) AR035813A1 (de)
BG (1) BG108220A (de)
BR (1) BR0208900A (de)
CA (1) CA2442695A1 (de)
CZ (1) CZ20032975A3 (de)
DE (1) DE10117204A1 (de)
EA (1) EA200301005A1 (de)
EC (1) ECSP034776A (de)
EE (1) EE200300491A (de)
HU (1) HUP0303737A3 (de)
IL (1) IL158254A0 (de)
MX (1) MXPA03008896A (de)
NO (1) NO20034434L (de)
PE (1) PE20021058A1 (de)
PL (1) PL366458A1 (de)
SK (1) SK12412003A3 (de)
WO (1) WO2002081445A1 (de)
ZA (1) ZA200307306B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
US20060154939A1 (en) * 2004-12-24 2006-07-13 Boehringer Ingelheim International Gmbh Medicaments for the Treatment or Prevention of Fibrotic Diseases
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
NZ584454A (en) 2007-10-12 2011-09-30 Ingenium Pharmaceuticals Gmbh N-[6-phenyl-pyrimidin-4-yl]-amides and urea derivatives as inhibitors of protein kinases
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2010009166A1 (en) * 2008-07-14 2010-01-21 Gilead Colorado, Inc. Oxindolyl inhibitor compounds
PE20110213A1 (es) * 2008-07-29 2011-04-16 Boehringer Ingelheim Int Derivados de indolinona como inhibidores de quinasa
CN102834380B (zh) 2010-03-10 2015-04-01 阿斯利康公司 蛋白激酶的抑制剂
CN102267934B (zh) * 2010-06-02 2013-04-17 金凯美(大连)医药科技有限公司 一种6-甲氧羰基吲哚酮的制备方法
EP3722291B1 (de) * 2015-12-24 2023-07-19 Respivert Limited Indolinon-verbindungen und deren verwendung zur behandlung von fibrotischen krankheiten
JP7039480B2 (ja) * 2016-03-08 2022-03-22 レスピバート・リミテツド プロテインキナーゼ阻害剤としてのインドール誘導体およびそれらの使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251741T3 (es) * 1996-08-23 2006-05-01 Sugen, Inc. Bibliotecas combinatorias de indolinona y productos afines y metodos para el tratamiento de enfermedades.
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6043254A (en) * 1998-04-03 2000-03-28 Boehringer Ingelheim Pharma Kg Indolinones having kinase-inhibiting activity
DE19816624A1 (de) 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6169106B1 (en) * 1998-04-15 2001-01-02 Boehringer Ingelheim Pharma Kg Indolinones having kinase inhibitory activity
DE19824922A1 (de) 1998-06-04 1999-12-09 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6319918B1 (en) * 1998-06-04 2001-11-20 Boehringer Ingelheim Pharma Kg Substituted indolinones with kinase inhibitory activity
DE19924401A1 (de) 1999-05-27 2000-11-30 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
EP1212318B1 (de) 1999-08-27 2006-01-25 Boehringer Ingelheim Pharma GmbH & Co.KG Substituierte indolinone als tyrosinkinase inhibitoren
DE19940829A1 (de) 1999-08-27 2001-03-01 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
UA75054C2 (uk) 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10042696A1 (de) 2000-08-31 2002-03-14 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
PL366458A1 (en) 2005-02-07
EP1379501A1 (de) 2004-01-14
EA200301005A1 (ru) 2004-04-29
WO2002081445A1 (de) 2002-10-17
ECSP034776A (es) 2003-12-01
CZ20032975A3 (cs) 2004-02-18
SK12412003A3 (sk) 2004-04-06
KR20030090712A (ko) 2003-11-28
US6858641B2 (en) 2005-02-22
ZA200307306B (en) 2004-08-31
IL158254A0 (en) 2004-05-12
PE20021058A1 (es) 2003-01-20
NO20034434D0 (no) 2003-10-03
CN1509270A (zh) 2004-06-30
BG108220A (bg) 2004-09-30
US20030092756A1 (en) 2003-05-15
HUP0303737A3 (en) 2004-09-28
NO20034434L (no) 2003-10-03
BR0208900A (pt) 2004-04-20
MXPA03008896A (es) 2003-12-08
HUP0303737A2 (hu) 2004-03-01
JP2004525173A (ja) 2004-08-19
DE10117204A1 (de) 2002-10-10
AR035813A1 (es) 2004-07-14
CA2442695A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
EE200200715A (et) Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
EE200300459A (et) Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
IS6968A (is) Nýir týrósínkínasa tálmar
DK1419152T3 (da) HIV-hæmmende pyrimidin-derivater
ATE505471T1 (de) Azaindol-kinaseinhibitoren
EE200300085A (et) Pürasooli derivaadid ja nende kasutamine proteiini kinaasi inhibiitoritena
ATE446093T1 (de) Substituierte chinazolin-derivate als aurora- kinase inhibitoren
DK1650203T3 (da) Quinolinonderivater som tyrosinkinaseinhibitorer
IL161516A0 (en) Benzimidazoles useful as protein kinase inhibitors
IS7700A (is) Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar
IS6524A (is) 5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar
NO20021820D0 (no) Tyrosinkinaseinhibitorer
DE60328735D1 (de) Chinazolinderivate
DK1361880T3 (da) 6-substituerede pyrido-pyrimidiner
EE200300491A (et) 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
NO20042742L (no) Pyrimidinforbindelser
NO20043580L (no) Quinazolinonderivater og deres bruk som CB agonister
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
NO20040175L (no) Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
NO20041938L (no) Anvendelse av fosfodiesterase IV-inhibitorer
DE60215804D1 (de) 4-aminopyrimidine derivate
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate